NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $2.49 | Prev. Close $2.49 | Circuit Range N/A |
Day Range $2.46 - $2.62 | Year Range $1.12 - $6.01 | Volume 10,861 |
Average Traded $2.54 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $2.49 | $2.59 | +0.00% |
12-Nov-25 | $2.49 | $2.59 | +4.02% |
11-Nov-25 | $2.48 | $2.49 | -1.78% |
10-Nov-25 | $2.56 | $2.54 | +3.89% |
07-Nov-25 | $2.66 | $2.44 | -8.61% |
06-Nov-25 | $2.67 | $2.67 | +0.19% |
05-Nov-25 | $2.77 | $2.67 | -3.09% |